Unleashing immuno-mass spectrometry superpowers to detect SARS-CoV-2
In this article of EBioMedicine, Santosh Renuse and colleagues1 show the relevance of combining immunoaffinity capture with targeted mass spectrometry measurement to detect SARS-CoV-2 nucleocapsid proteins in nasopharyngeal swab samples. The COVID-19 pandemic has confirmed the need to improve the to...
Main Author: | Jean Armengaud |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-07-01
|
Series: | EBioMedicine |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352396421002735 |
Similar Items
-
An Optimized High-Throughput Immuno-Plaque Assay for SARS-CoV-2
by: Alberto A. Amarilla, et al.
Published: (2021-02-01) -
SARS-CoV-2, the other face to SARS-CoV and MERS-CoV: Future predictions
by: T.M. Abdelghany, et al.
Published: (2021-03-01) -
Data mining of coronavirus: SARS-CoV-2, SARS-CoV and MERS-CoV
by: Jung Eun Huh, et al.
Published: (2021-04-01) -
The Comparative Immunological Characteristics of SARS-CoV, MERS-CoV, and SARS-CoV-2 Coronavirus Infections
by: Yun-yu Zhang, et al.
Published: (2020-08-01) -
Epitope based vaccine prediction for SARS-COV-2 by deploying immuno-informatics approach
by: Amit Joshi, et al.
Published: (2020-01-01)